Clinicians Need Better Understanding Of Drug-Resistant TB To Maximize Treatment Results, Survey Shows

Center for Global Health Policy’s “Science Speaks”: Multi-country survey sheds light on drug-resistant tuberculosis treatment needs
Antigone Barton, senior editor and writer of “Science Speaks,” discusses a survey published in The Lancet Infectious Diseases that “shows a need for better understanding of the dynamics of drug-resistant [tuberculosis], including through tests that do not yet exist. The survey’s findings … show that tuberculosis that is resistant to the most common first-line drug may often also be resistant to a drug used in substitute therapies…” (7/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.